Efficacy and toxicity of capecitabine-based chemotherapy in patients with metastatic or advanced breast cancer: results from ten randomized trials

Author： Wang Yongqing   Yang Haiwei   Wei Ji-Fu   Meng Ling  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.12, 2012-12, pp. : 1911-1919

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of gemcitabine-based chemotherapy in metastatic breast cancer: a meta-analysis of randomized controlled trials

By Li Weibing   Wang Hongbiao   Li Xuyuan  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1443-1452

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine in the Routine Treatment of Advanced Breast Cancer: Results from a Non-Interventional Observational Study in 876 Patients

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 631-636

Karger

Access to resources Recommend Favorite

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 262-268

Karger

Access to resources Recommend Favorite

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Efficacy and Tolerability of Capecitabine with Weekly Paclitaxel for Patients with Metastatic Breast Cancer: A Phase II Report of the SAKK

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 54-60

Karger

Access to resources Recommend Favorite